Cannell & Spears’s Steris STE Stock Holding History

Cannell & Spears’s Portfolio STE Stock Details STE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$213K	Buy	964 +1	+0.1%	+$245	﹤0.01%	395
2025 Q4	$244K	Hold	963	–	–	﹤0.01%	376
2025 Q3	$238K	Buy	963 +26	+3%	+$6.22K	﹤0.01%	371
2025 Q2	$225K	Hold	937	–	–	﹤0.01%	355
2025 Q1	$212K	Buy	+937	New	+$206K	﹤0.01%	363
2024 Q4	–	Sell	-935	Closed	-$227K	–	421
2024 Q3	$227K	Hold	935	–	–	﹤0.01%	370
2024 Q2	$205K	Hold	935	–	–	﹤0.01%	350
2024 Q1	$210K	Hold	935	–	–	﹤0.01%	360
2023 Q4	$206K	Hold	935	–	–	0.02%	207
2023 Q3	$205K	Hold	935	–	–	0.02%	198
2023 Q2	$210K	Buy	+935	New	+$187K	0.02%	212

Other funds holding STE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Cannell & Spears's STE Position: Q1 2026 in Review

Cannell & Spears increased its Steris (STE) stake by 0.1% in Q1 2026, buying an estimated $245 and bringing the position to 964 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #395.

Cannell & Spears first reported a position in STE in Q2 2023 and has held it in 11 quarters since. The position peaked at $244K in Q4 2025. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

Cannell & Spears held 964 shares of Steris worth $213K as of Q1 2026.
Cannell & Spears bought 1 Steris share in Q1 2026, an estimated $245.
Steris made up ﹤0.01% of Cannell & Spears's portfolio in Q1 2026, its #395 holding.
Cannell & Spears first reported a position in Steris in Q2 2023 and has held it in 11 quarters since.
Cannell & Spears's Steris position peaked at $244K in Q4 2025.
838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.